RxDoctor Payments Data

Danielle Grontas, APRN

Family · Panama City, FLNPI 1497500805

Payments from drug & device makers

$787in general payments, 2019–2025

Across 36 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$254
  • AstraZeneca$92
  • Exact Sciences$62
  • Vanda Pharmaceuticals Inc.$62
  • Lundbeck LLC$57
  • Amgen$52
  • plus $209 from 7 others

What the payments were for

  • Food & beverage$787100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$787 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$19,665
Medicare patients
129
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide20$22,412
EliquisApixaban14$20,822
OzempicSemaglutide14$12,921
MyrbetriqMirabegron11$8,668
Albuterol Sulfate HfaAlbuterol Sulfate34$1,382
Buspirone Hcl26$766
Ondansetron Hcl21$626
Atorvastatin Calcium58$564
Fluticasone Propionate25$473
Levothyroxine Sodium34$470
Losartan Potassium40$468
Gabapentin22$444
Omeprazole35$436
Amlodipine Besylate51$273
ClopidogrelClopidogrel Bisulfate30$270

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$38$22,41220 claims
Novo NordiskOzempic$254$12,92114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Panama City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →